We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Biotech Collaboration to Promote Animal-Based Cancer Research

By LabMedica International staff writers
Posted on 05 Apr 2015
Print article
Two American biotechnology companies have signed a collaboration agreement that is intended to promote animal-based cancer research and drug development.

The two companies, Taconic Biosciences (Hudson, NY, USA) and Cellaria Biosciences (Boxford, Massachusetts, USA) possess complementary technical expertise that, when combined, will facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and cancer drug research. Cellaria is known for the development of novel methodologies for generating cells from patient tumors and will benefit from Taconic’s portfolio of tissue humanized mouse models.

The initial project to be conducted under the collaboration agreement will focus on the creation of breast cancer cell lines from PDX models for which Taconic holds licenses from the University of Utah (Salt Lake City, USA).

“Our scientific collaboration with Cellaria is a prime example of Taconic continually pushing the boundaries of technology to improve the utility of humanized animal models in biomedical research,” said Todd Little, president of corporate development at Taconic Biosciences. “By collaborating with a company that has achieved great success in generating cell lines from patient-derived tumors, Taconic will be able to deliver more predictive tissue humanized models that will improve and accelerate oncology research and drug discovery.”

“Taconic and Cellaria have a shared goal to create relevant tools for cancer,” said David Deems, CEO of Cellaria Biosciences. “The new models created through this collaboration have enormous potential to better define target patient populations and evaluate the efficacy of new therapies.”

Related Links:

Taconic Biosciences
Cellaria Biosciences
University of Utah


New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Silver Member
Static Concentrator
BJP 10
New
Progesterone Serum Assay
Progesterone ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.